Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures
Chronic exposure to toxigenic molds in water-damaged buildings is an indoor environmental health problem to which escalating health and property insurance costs are raising a statewide concern in recent times. This paper reviews the structural and functional properties of mycotoxins produced by toxi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2004-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2004.22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553247670272000 |
|---|---|
| author | Ebere C. Anyanwu Andrew W. Campbell John E. Ehiri |
| author_facet | Ebere C. Anyanwu Andrew W. Campbell John E. Ehiri |
| author_sort | Ebere C. Anyanwu |
| collection | DOAJ |
| description | Chronic exposure to toxigenic molds in water-damaged buildings is an indoor environmental health problem to which escalating health and property insurance costs are raising a statewide concern in recent times. This paper reviews the structural and functional properties of mycotoxins produced by toxigenic molds and their interactive health implications with antifungal drugs. Fundamental bases of pathophysiological, neurodevelopmental, and cellular mechanisms of mycotoxic effects are evaluated. It is most likely that the interactions of mycotoxins with antifungal drugs may, at least in part, contribute to the observable persistent illnesses, antifungal drug resistance, and allergic reactions in patients exposed to chronic toxigenic molds. Safe dose level of mycotoxin in humans is not clear. Hence, the safety regulations in place at the moment remain inconclusive, precautionary, and arbitrary. Since some of the antifungal drugs are derived from molds, and since they have structural and functional groups similar to those of mycotoxins, the knowledge of their interactions are important in enhancing preventive measures. |
| format | Article |
| id | doaj-art-26a46f838b9c4e7aad5d7c025fdf3410 |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2004-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-26a46f838b9c4e7aad5d7c025fdf34102025-02-03T05:54:28ZengWileyThe Scientific World Journal1537-744X2004-01-01416717710.1100/tsw.2004.22Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold ExposuresEbere C. Anyanwu0Andrew W. Campbell1John E. Ehiri2Cahers Neurosciences Research, Inc., 8787 Shenandoah Park Drive, Suite 122, Conroe, TX 77385, USAMedical Center for Immune, Environmental, and Toxic Disorders, Spring, TX, USADepartment of Maternal and Child Health, School of Public Health, University of Alabama at Birmingham (UAB), Ryals Public Health Building, 1665 University Boulevard, Birmingham, AL 35294-0022, USAChronic exposure to toxigenic molds in water-damaged buildings is an indoor environmental health problem to which escalating health and property insurance costs are raising a statewide concern in recent times. This paper reviews the structural and functional properties of mycotoxins produced by toxigenic molds and their interactive health implications with antifungal drugs. Fundamental bases of pathophysiological, neurodevelopmental, and cellular mechanisms of mycotoxic effects are evaluated. It is most likely that the interactions of mycotoxins with antifungal drugs may, at least in part, contribute to the observable persistent illnesses, antifungal drug resistance, and allergic reactions in patients exposed to chronic toxigenic molds. Safe dose level of mycotoxin in humans is not clear. Hence, the safety regulations in place at the moment remain inconclusive, precautionary, and arbitrary. Since some of the antifungal drugs are derived from molds, and since they have structural and functional groups similar to those of mycotoxins, the knowledge of their interactions are important in enhancing preventive measures.http://dx.doi.org/10.1100/tsw.2004.22 |
| spellingShingle | Ebere C. Anyanwu Andrew W. Campbell John E. Ehiri Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures The Scientific World Journal |
| title | Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures |
| title_full | Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures |
| title_fullStr | Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures |
| title_full_unstemmed | Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures |
| title_short | Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures |
| title_sort | mycotoxins and antifungal drug interactions implications in the treatment of illnesses due to indoor chronic toxigenic mold exposures |
| url | http://dx.doi.org/10.1100/tsw.2004.22 |
| work_keys_str_mv | AT eberecanyanwu mycotoxinsandantifungaldruginteractionsimplicationsinthetreatmentofillnessesduetoindoorchronictoxigenicmoldexposures AT andrewwcampbell mycotoxinsandantifungaldruginteractionsimplicationsinthetreatmentofillnessesduetoindoorchronictoxigenicmoldexposures AT johneehiri mycotoxinsandantifungaldruginteractionsimplicationsinthetreatmentofillnessesduetoindoorchronictoxigenicmoldexposures |